FCCC LOGO Faculty Publications
Coit DG , Thompson JA , Algazi A , Andtbacka R , Bichakjian CK , Carson WE 3rd , Daniels GA , DiMaio D , Fields RC , Fleming MD , Gastman B , Gonzalez R , Guild V , Johnson D , Joseph RW , Lange JR , Martini MC , Materin MA , Olszanski AJ , Ott P , Gupta AP , Ross MI , Salama AK , Skitzki J , Swetter SM , Tanabe KK , Torres-Roca JF , Trisal V , Urist MM , McMillian N , Engh A
NCCN Guidelines Insights: Melanoma, Version 3.2016
J Natl Compr Canc Netw. 2016 Aug;14(8) :945-58
PMID: 27496110   
Back to previous list
Abstract
The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN Guidelines Insights summarize the data and rationale supporting extensive changes to the recommendations for systemic therapy in patients with metastatic or unresectable melanoma.
Notes
Coit, Daniel G Thompson, John A Algazi, Alain Andtbacka, Robert Bichakjian, Christopher K Carson, William E 3rd Daniels, Gregory A DiMaio, Dominick Fields, Ryan C Fleming, Martin D Gastman, Brian Gonzalez, Rene Guild, Valerie Johnson, Douglas Joseph, Richard W Lange, Julie R Martini, Mary C Materin, Miguel A Olszanski, Anthony J Ott, Patrick Gupta, Aparna Priyanath Ross, Merrick I Salama, April K Skitzki, Joseph Swetter, Susan M Tanabe, Kenneth K Torres-Roca, Javier F Trisal, Vijay Urist, Marshall M McMillian, Nicole Engh, Anita United States J Natl Compr Canc Netw. 2016 Aug;14(8):945-58.